A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Clinical trial NCT07094204 · RECRUITING

Trial details

NCT number: NCT07094204
Sponsor: Astellas Pharma Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non-Small-Cell Lung Cancer Pancreatic Ductal Adenocarcinoma Colorectal Cancer

Start date: 2025-07-25
Primary completion: 2028-11-30
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.